Researchers engineered a quipazine analog that selectively targeted 5-HT2A receptors. In mice, it promoted brain plasticity ...

A new startup is making a bold move in the world of obesity drug development: It’s not working with the GLP-1 target that has ...

Vertex Pharma to buy Crinetics Pharmaceuticals for $10 billion: Boston Wednesday, July 8, 2026, 14:00 Hrs [IST] Vertex Pharmaceuticals Incorporated, a global biotechnology company ...

Uterine fibroids and endometriosis are two of the most common gynecologic diseases, affecting 15% to 80% of women of ...

Ligand-gated ion channels are ion channels that are opened or closed (gated) by ligands, generally small molecules such as the second messenger cAMP and neurotransmitters. Ligand-gated ion channels ...

Nanotechnology has been applied extensively in drug delivery to improve the therapeutic outcomes of various diseases. Tremendous efforts have been focused on the development of novel nanoparticles and ...

LGND is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of LGND shares has decreased $1.21 since the market last closed. This is a 0.40% ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...